0001437749-23-005165.txt : 20230302
0001437749-23-005165.hdr.sgml : 20230302
20230302091812
ACCESSION NUMBER: 0001437749-23-005165
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230228
FILED AS OF DATE: 20230302
DATE AS OF CHANGE: 20230302
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Reich Samuel J
CENTRAL INDEX KEY: 0001394645
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39871
FILM NUMBER: 23696660
MAIL ADDRESS:
STREET 1: ACUITY PHARMACEUTICALS INC
STREET 2: 3701 MARKET STREET
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SAB Biotherapeutics, Inc.
CENTRAL INDEX KEY: 0001833214
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 853899721
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2100 EAST 54TH STREET NORTH
CITY: SIOUX FALLS
STATE: SD
ZIP: 57104
BUSINESS PHONE: 605-679-6980
MAIL ADDRESS:
STREET 1: 2100 EAST 54TH STREET NORTH
CITY: SIOUX FALLS
STATE: SD
ZIP: 57104
FORMER COMPANY:
FORMER CONFORMED NAME: Big Cypress Acquisition Corp.
DATE OF NAME CHANGE: 20201120
4
1
rdgdoc.xml
FORM 4
X0306
4
2023-02-28
0001833214
SAB Biotherapeutics, Inc.
SABS
0001394645
Reich Samuel J
2100 E 54TH STREET NORTH
SIOUX FALLS
SD
57104
1
1
Executive Chairman
Warrants
11.50
2023-02-28
4
J
0
208600
0
D
2022-01-14
2026-10-20
Common Stock
208600
0
I
Via Big Cypress Holdings LLC
Warrants
11.50
2023-02-28
4
J
0
9968
0
A
2022-01-14
2026-10-20
Common Stock
9968
9968
D
Pro rata distribution by Big Cypress Holdings LLC to its members for which no consideration is being paid in connection with such distribution. The Reporting Person is a managing member of Big Cypress Holdings LLC, and as part of the distribution received 9,968 warrants of the issuer, which the Reporting Person previously had an indirect pecuniary interest.
The Reporting Person received 9,968 warrants as part of the distribution, which the Reporting Person previously had an indirect pecuniary interest. Therefore, the transaction, which only changes the form of the Reporting Person's ownership without increasing or decreasing his pecuniary interest, is exempt from the reporting requirements of Section 16 pursuant to Rule 16a-13. Notwithstanding, the Reporting Person is reporting the acquisition on a voluntary basis.
/s/ Samuel J. Reich
2023-03-02